Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MICHAEL BANOV

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1881771004
CMS profile
311843
Location
MARIETTA, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$158,399.73

287 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Page 2 of 6; records 51–100 of 287 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MICHAEL BANOV

NPI 1881771004 · CMS profile ID 311843

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry

MARIETTA, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 6; records 51–100 of 287 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1881771004?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MICHAEL BANOV, NPI 1881771004, CMS profile ID 311843. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 6; records 51–100 of 287 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1881771004?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). MICHAEL BANOV, NPI 1881771004, CMS profile ID 311843. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 6; records 51–100 of 287 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1881771004?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
MICHAEL BANOV, NPI 1881771004, CMS profile ID 311843, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 6; records 51–100 of 287 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1881771004?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

287 matching records · $158,399.73 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 287 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 287.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Axsome Therapeutics, Inc. $2,475.0010/15/2025 Honoraria No dispute reported Delay: No
Change: NEW
06/30/2026 1235755859 CMS
Axsome Therapeutics, Inc. $24.5010/15/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1235810188 CMS
Alkermes, Inc. $29.3910/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222441832 CMS
ABBVIE INC. $5.0210/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201469523 CMS
ABBVIE INC. $18.3910/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201469519 CMS
ABBVIE INC. $22.4010/09/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1201469521 CMS
E.R. Squibb & Sons, L.L.C. $134.9910/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184665280 CMS
E.R. Squibb & Sons, L.L.C. $49.9910/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184665284 CMS
E.R. Squibb & Sons, L.L.C. $29.9910/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184665287 CMS
E.R. Squibb & Sons, L.L.C. $29.9910/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184665292 CMS
E.R. Squibb & Sons, L.L.C. $602.6110/09/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1184665296 CMS
E.R. Squibb & Sons, L.L.C. $64.9910/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184665300 CMS
E.R. Squibb & Sons, L.L.C. $326.0910/09/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1184665304 CMS
E.R. Squibb & Sons, L.L.C. $51.7310/09/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1184665308 CMS
Axsome Therapeutics, Inc. $23.3210/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235542124 CMS
ABBVIE INC. $5.5010/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201469517 CMS
Vanda Pharmaceuticals Inc. $24.6810/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232946309 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $138.5310/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241253120 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.2910/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241253122 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.2910/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241253124 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $275.4510/04/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1241253126 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $43.7510/04/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1241253128 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $46.6410/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241253130 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $52.9410/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241253132 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $526.9710/04/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1241253134 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $59.4310/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241253136 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $68.7510/04/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1241253138 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $26.8710/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241253118 CMS
Tris Pharma Inc $21.8410/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1192255911 CMS
ABBVIE INC. $125.0009/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201469507 CMS
ABBVIE INC. $85.4009/30/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1201469509 CMS
ABBVIE INC. $19.8609/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201469511 CMS
ABBVIE INC. $30.1009/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201469513 CMS
ABBVIE INC. $85.4009/30/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1201469515 CMS
ABBVIE INC. $5.0209/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201469505 CMS
Supernus Pharmaceuticals, Inc. $13.7909/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244873821 CMS
ABBVIE INC. $21.7809/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201469501 CMS
ABBVIE INC. $43.4009/25/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1201469503 CMS
ACADIA Pharmaceuticals Inc $22.3809/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247766257 CMS
Vanda Pharmaceuticals Inc. $25.6909/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232946304 CMS
ABBVIE INC. $2.3709/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201469499 CMS
Collegium Pharmaceutical, Inc. $21.8209/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224241246 CMS
Teva Pharmaceuticals USA, Inc. $18.2409/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247306145 CMS
Vanda Pharmaceuticals Inc. $0.8909/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232946277 CMS
Vanda Pharmaceuticals Inc. $119.5509/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232946281 CMS
Vanda Pharmaceuticals Inc. $2,600.0009/10/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1232946285 CMS
Vanda Pharmaceuticals Inc. $52.5009/10/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1232946289 CMS
Vanda Pharmaceuticals Inc. $23.6609/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232946293 CMS
Vanda Pharmaceuticals Inc. $2,600.0009/10/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1232946297 CMS
Vanda Pharmaceuticals Inc. $72.1009/10/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1232946300 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $79,589.71 257
PY2020 $28,876.43 120
PY2021 $67,958.87 256
PY2022 $103,692.97 249
PY2023 $147,036.65 306
PY2024 $147,215.17 287
PY2025 $158,399.73 287

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $158,344.45 75
PY2024 Principal investigator $202,575.94 78
PY2023 Principal investigator $390,338.41 115
PY2022 Principal investigator $396,019.30 118
PY2021 Principal investigator $671,834.50 104
PY2020 Principal investigator $1,069,472.33 92
PY2019 Recipient $208,332.03 49
PY2019 Principal investigator $584,103.07 84

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

75 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $3,132.24 12/31/2025 Non-covered Recipient Entity
NORTHWEST BEHAVIORAL RESEARCH CENTER
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study to Evaluate the Efficacy, Safety, and Tolerability of ABBV-932 as an Adjunct to Antidepressant Therapies in the Treatment of Subjects with Generalized Anxiety Disorder who have had an Inadequate Response to Antidepressant Therapies No dispute reported 06/30/2026 1202532733
Principal investigator 1 ABBVIE INC. $4,439.61 12/31/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder No dispute reported 06/30/2026 1202535267
Principal investigator 1 ABBVIE INC. $3,468.15 12/04/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder No dispute reported 06/30/2026 1202528026
Principal investigator 1 LivaNova USA, Inc. $452.25 11/11/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545708
Principal investigator 1 LivaNova USA, Inc. $1,512.00 10/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545592
Principal investigator 1 LivaNova USA, Inc. $101.25 10/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545596
Principal investigator 1 LivaNova USA, Inc. $452.25 10/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545600
Principal investigator 1 LivaNova USA, Inc. $1,512.00 10/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545655
Principal investigator 1 LivaNova USA, Inc. $1,512.00 10/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545659
Principal investigator 1 LivaNova USA, Inc. $1,512.00 10/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545663
Principal investigator 1 LivaNova USA, Inc. $101.25 10/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545667
Principal investigator 1 LivaNova USA, Inc. $1,512.00 09/09/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545587
Principal investigator 1 LivaNova USA, Inc. $1,512.00 09/09/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545651
Principal investigator 1 LivaNova USA, Inc. $1,512.00 08/09/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545575
Principal investigator 1 LivaNova USA, Inc. $101.25 08/09/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545579
Principal investigator 1 LivaNova USA, Inc. $452.25 08/09/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545583
Principal investigator 1 LivaNova USA, Inc. $1,512.00 08/09/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545620
Principal investigator 1 LivaNova USA, Inc. $1,512.00 08/09/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545623
Principal investigator 1 LivaNova USA, Inc. $1,512.00 08/09/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545627
Principal investigator 1 LivaNova USA, Inc. $1,512.00 08/09/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545631
Principal investigator 1 LivaNova USA, Inc. $101.25 08/09/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545635
Principal investigator 1 LivaNova USA, Inc. $101.25 08/09/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545639
Principal investigator 1 LivaNova USA, Inc. $452.25 08/09/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545643
Principal investigator 1 LivaNova USA, Inc. $452.25 08/09/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545647
Principal investigator 1 LivaNova USA, Inc. $1,345.00 08/07/2025 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 1245557012
Principal investigator 1 LivaNova USA, Inc. $90.00 06/17/2025 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 1245556664
Principal investigator 1 LivaNova USA, Inc. $101.25 06/10/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545433
Principal investigator 1 LivaNova USA, Inc. $452.25 06/10/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545437
Principal investigator 1 LivaNova USA, Inc. $1,512.00 06/10/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545563
Principal investigator 1 LivaNova USA, Inc. $1,512.00 06/10/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545567
Principal investigator 1 LivaNova USA, Inc. $1,512.00 06/10/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545571
Principal investigator 1 LivaNova USA, Inc. $1,512.00 06/10/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545874
Principal investigator 1 ABBVIE INC. $11,027.00 06/03/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder No dispute reported 06/30/2026 1202489407
Principal investigator 1 LivaNova USA, Inc. $1,377.00 05/09/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545857
Principal investigator 1 LivaNova USA, Inc. $1,512.00 05/09/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545862
Principal investigator 1 LivaNova USA, Inc. $101.25 05/09/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545866
Principal investigator 1 LivaNova USA, Inc. $452.25 05/09/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545870
Principal investigator 1 LivaNova USA, Inc. $452.25 05/09/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545883
Principal investigator 1 LivaNova USA, Inc. $1,377.00 04/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545845
Principal investigator 1 LivaNova USA, Inc. $1,512.00 04/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545848
Principal investigator 1 LivaNova USA, Inc. $101.25 04/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545853
Principal investigator 1 LivaNova USA, Inc. $1,512.00 04/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545891
Principal investigator 1 LivaNova USA, Inc. $1,512.00 04/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545896
Principal investigator 1 LivaNova USA, Inc. $101.25 04/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545901
Principal investigator 1 LivaNova USA, Inc. $1,512.00 03/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545809
Principal investigator 1 LivaNova USA, Inc. $101.25 03/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545813
Principal investigator 1 LivaNova USA, Inc. $452.25 03/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545818
Principal investigator 1 LivaNova USA, Inc. $1,512.00 03/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545905
Principal investigator 1 LivaNova USA, Inc. $452.25 03/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545910
Principal investigator 1 LivaNova USA, Inc. $1,512.00 03/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245546091
Principal investigator 1 LivaNova USA, Inc. $1,512.00 03/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245546096
Principal investigator 1 LivaNova USA, Inc. $101.25 03/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245546101
Principal investigator 1 LivaNova USA, Inc. $452.25 03/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245546105
Principal investigator 1 LivaNova USA, Inc. $430.00 02/11/2025 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 1245556558
Principal investigator 1 LivaNova USA, Inc. $430.00 02/11/2025 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 1245556616
Principal investigator 1 LivaNova USA, Inc. $1,512.00 02/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545756
Principal investigator 1 LivaNova USA, Inc. $1,377.00 02/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545760
Principal investigator 1 LivaNova USA, Inc. $101.25 02/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545765
Principal investigator 1 LivaNova USA, Inc. $452.25 02/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545770
Principal investigator 1 LivaNova USA, Inc. $519.75 02/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545775
Principal investigator 1 LivaNova USA, Inc. $101.25 02/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545806
Principal investigator 1 Boehringer Ingelheim Pharmaceuticals, Inc. $9,000.00 02/06/2025 Non-covered Recipient Entity
Psych Atlanta, PC
Phase II dose finding trial in monotherapy for MDD No dispute reported 06/30/2026 1220813301
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $53,645.88 01/17/2025 Non-covered Recipient Entity
Psych Atlanta
An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia No dispute reported 06/30/2026 1235994433
Principal investigator 1 LivaNova USA, Inc. $1,512.00 01/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545740
Principal investigator 1 LivaNova USA, Inc. $1,377.00 01/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545744
Principal investigator 1 LivaNova USA, Inc. $101.25 01/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545748
Principal investigator 1 LivaNova USA, Inc. $452.25 01/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545752
Principal investigator 1 LivaNova USA, Inc. $1,512.00 01/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545788
Principal investigator 1 LivaNova USA, Inc. $1,512.00 01/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545792
Principal investigator 1 LivaNova USA, Inc. $1,512.00 01/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545797
Principal investigator 1 LivaNova USA, Inc. $101.25 01/08/2025 Non-covered Recipient Entity
PSYCH ATLANTA PC
RECOVER No dispute reported 06/30/2026 1245545801
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $15,411.43 01/06/2025 Non-covered Recipient Entity
Psych Atlanta
A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia (ARISE) No dispute reported 06/30/2026 1235994435
Principal investigator 1 Boehringer Ingelheim International GmbH $45.00 01/01/2025 Non-covered Recipient Entity
Hightop Health-Marietta
Phase II dose finding trial in monotherapy for MDD No dispute reported 06/30/2026 1220692445
Principal investigator 1 Boehringer Ingelheim International GmbH $45.00 01/01/2025 Non-covered Recipient Entity
Hightop Health-Marietta
Phase II dose finding trial in monotherapy for MDD No dispute reported 06/30/2026 1220692447
Principal investigator 1 Boehringer Ingelheim International GmbH $73.39 01/01/2025 Non-covered Recipient Entity
Hightop Health-Marietta
Phase II dose finding trial in monotherapy for MDD No dispute reported 06/30/2026 1220692449